The Peripheral Intravenous Catheter Market has been segmented by Product Type into Short PIVC, Ported PIVC, Non-ported PIVC and Integrated/closed PIVC.

Short PIVC

Short Peripheral Intravenous Catheters (PIVCs) dominate the global market, contributing over 60% to total revenue. Their widespread use is attributed to quick insertion, lower cost, and suitability for short-term therapies in hospitals, clinics, and emergency departments.

Ported PIVC

Ported PIVCs account for approximately 25% of the market. These devices offer an added injection port for multiple medication administrations, reducing the need for repeated venipuncture. Their ease of use and versatility make them common in surgical and acute care environments.

Non-ported PIVC

Non-ported Peripheral Intravenous Catheters represent around 10% of market usage. Designed for single-line access, they are favored in controlled clinical scenarios where infection risk is a concern. Their simplicity is ideal for pediatric and specialized care applications.

Integrated/Closed PIVC

Integrated or closed system PIVCs are gaining momentum, currently holding a 5% share of the market. These catheters combine safety and infection control, reducing needlestick injuries and bloodstream infections, making them attractive in hospitals with strict hygiene standards.

Peripheral Intravenous Catheter Market, Segmentation by Technology

The Peripheral Intravenous Catheter Market has been segmented by Technology into Conventional PIVC and Safety PIVC.

Conventional PIVC

Conventional Peripheral Intravenous Catheters (PIVCs) continue to hold a significant market share, contributing around 55% globally. These catheters are widely used due to their low cost and clinical familiarity. However, their adoption is gradually declining due to safety concerns and rising preference for advanced alternatives.

Safety PIVC

Safety PIVCs are experiencing increased demand, currently occupying nearly 45% of the market. Designed to minimize needlestick injuries and reduce the risk of bloodstream infections, they are preferred in healthcare facilities focused on improving staff safety and patient outcomes.

Peripheral Intravenous Catheter Market, Segmentation by Lumen

The Peripheral Intravenous Catheter Market has been segmented by Lumen into Single Lumen, Double Lumen, and Multi-Lumen.

Single Lumen

Single lumen catheters dominate the market with a share of over 65%, owing to their simplicity, ease of insertion, and cost-efficiency. They are widely used for routine fluid administration, medication delivery, and blood sampling in general medical and surgical care settings.

Double Lumen

Double lumen catheters account for nearly 25% of market usage. These catheters allow simultaneous administration of multiple therapies, making them ideal for patients in intensive care or undergoing complex treatments such as chemotherapy or total parenteral nutrition.

Multi-Lumen

Multi-lumen catheters hold a smaller but growing share of approximately 10%. Their design supports advanced clinical applications requiring multiple infusions or blood draws, and they are primarily used in critical care, emergency response, and specialized procedures.

Peripheral Intravenous Catheter Market, Segmentation by End-user

The Peripheral Intravenous Catheter Market has been segmented by End-user into Hospitals, Ambulatory surgical centres, Clinics, Home use and Others.

Hospitals

Hospitals represent the largest end-user segment, contributing over 50% of the total market share. Their high patient volume, advanced infrastructure, and wide range of intravenous therapies drive the significant demand for Peripheral Intravenous Catheters in inpatient and surgical care units.

Ambulatory Surgical Centres

Ambulatory surgical centres account for approximately 20% of the market. These facilities prefer PIVCs for their ease of use and efficiency in outpatient procedures. Rapid patient turnover and minimally invasive surgeries support steady adoption in this segment.

Clinics

Clinics hold a 15% share, using PIVCs primarily for diagnostic and therapeutic interventions. The rising number of private and specialty clinics globally, along with expanding healthcare access, is contributing to steady market growth in this segment.

Home Use

Home use applications are growing, with around 10% market share, driven by the increasing preference for home-based care. PIVCs are used for patients requiring routine medication, hydration therapy, or palliative care, supported by remote monitoring and nursing services.

Others

Others comprise specialized care settings such as nursing homes, mobile medical units, and military healthcare services. Though currently a small share of around 5%, this segment is expanding with the diversification of healthcare delivery models across regions.

Peripheral Intravenous Catheter Market, Segmentation by Geography

In this report, the Peripheral Intravenous Catheter Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

North America

North America leads the global Peripheral Intravenous Catheter market with over 35% share, driven by advanced healthcare infrastructure, high hospitalization rates, and strong adoption of safety PIVCs. The presence of major market players and favorable reimbursement policies further support regional growth.

Europe

Europe holds approximately 30% of the market, supported by increasing surgical procedures, aging population, and stringent safety regulations. Rising demand for infection-prevention devices and strong government healthcare spending continue to fuel market expansion across major EU nations.

Asia Pacific

Asia Pacific is witnessing the fastest growth, contributing nearly 20% to global share. Factors such as growing healthcare investments, expanding hospital infrastructure, and rising awareness of intravenous therapy are accelerating market penetration, especially in China, India, and Southeast Asia.

Middle East and Africa

Middle East and Africa collectively represent around 8% of the market. Though still emerging, the region benefits from increasing public-private healthcare partnerships, improving access to care, and gradual adoption of modern vascular access devices.

Latin America

Latin America accounts for approximately 7% of global share. Market growth is fueled by rising hospital admissions, improving healthcare standards, and increasing awareness about safe infusion practices, particularly in countries like Brazil, Mexico, and Argentina.

Drivers

• Technological Advancements

• Increasing Surgical Procedures - The global market for peripheral intravenous (IV) catheters is witnessing substantial growth, driven primarily by an increase in surgical procedures worldwide. As healthcare systems evolve and populations grow older, the demand for surgical interventions continues to rise. Peripheral IV catheters play a crucial role in these procedures by providing access to medications, fluids, and blood products directly into the patient's bloodstream. This functionality is essential not only during surgeries but also in post-operative care and in treating various medical conditions that require intravenous therapy.

  Advancements in medical technology have also contributed to the market's expansion. Innovations in catheter materials, designs, and insertion techniques have improved patient comfort, reduced complications such as infections, and enhanced overall efficacy. Moreover, healthcare providers are increasingly adopting peripheral IV catheters due to their convenience, cost-effectiveness, and ability to minimize patient discomfort compared to other forms of vascular access.

Restraints

• Risk of Infections

• Stringent Regulatory Guidelines - The global peripheral intravenous catheter market is significantly influenced by stringent regulatory guidelines governing medical devices. These guidelines are implemented to ensure the safety, efficacy, and quality of peripheral intravenous catheters used in healthcare settings worldwide. Regulatory bodies such as the FDA in the United States, the European Medicines Agency (EMA) in Europe, and similar authorities in other regions impose rigorous requirements on manufacturers regarding product design, manufacturing processes, and clinical trials.

  For manufacturers, navigating these regulatory frameworks is crucial as non-compliance can lead to delays in product approvals, costly recalls, or even market withdrawal. Compliance with regulatory guidelines necessitates thorough documentation of every aspect of the product lifecycle, from initial design and development to post-market surveillance. Manufacturers must conduct comprehensive risk assessments and clinical evaluations to demonstrate the safety and performance of their peripheral intravenous catheters before they can be marketed and sold.

  Healthcare providers also play a pivotal role in adhering to regulatory standards by ensuring proper training of personnel involved in catheter insertion and maintenance. This includes following established protocols for infection control and monitoring patient outcomes to comply with regulatory expectations for patient safety and quality of care. Overall, while stringent regulatory guidelines present challenges for stakeholders in the peripheral intravenous catheter market, they are essential for maintaining high standards of patient care and product reliability in the healthcare industry globally.

Opportunities

• Growing Healthcare Infrastructure

• Rising Demand in Emerging Markets - The global peripheral intravenous catheter market is experiencing a surge in demand, particularly in emerging markets, driven by several key factors. One significant driver is the increasing prevalence of chronic diseases and the subsequent rise in hospital admissions worldwide. Peripheral intravenous catheters are essential medical devices used for administering medications, fluids, and blood products, making them indispensable in healthcare settings. As emerging markets enhance their healthcare infrastructure and expand access to medical facilities, the demand for these catheters continues to grow.

  Technological advancements in peripheral intravenous catheters have contributed to their increased adoption in emerging markets. Innovations such as antimicrobial coatings, integrated safety features, and catheters designed for specific patient populations have improved safety, efficacy, and patient comfort, further fueling market growth. These developments not only address healthcare providers' needs for better infection control and patient care but also support the market expansion in regions where healthcare standards are rapidly improving.

  Economic growth and rising disposable incomes in emerging markets have bolstered healthcare expenditure, leading to increased investments in medical devices such as peripheral intravenous catheters. Governments and private healthcare providers in these regions are focusing on upgrading healthcare facilities and adopting advanced medical technologies, which in turn propels the demand for peripheral intravenous catheters. As the global healthcare landscape continues to evolve, the peripheral intravenous catheter market is poised for substantial growth, with emerging markets playing a pivotal role in shaping its expansion trajectory.